Melphalan flufenamide (melflufen) is approved in Europe for relapsed/refractory multiple myeloma, but the FDA withdrew its ...

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today announces the publication of new real-world data that further ...

Early infection incidence in patients with multiple myeloma following treatment with cilta-cel infusion highlights the ...

Two drug dealers who dealt drugs in their hometown have been jailed. Joshua Deakins, 21, of Spring Bank, Grimsby, pleaded guilty to two counts of being concerned in the supply of Class A drugs and ...

The drug helped lower patients’ blood sugar and reduce their weight by an average of 16 pounds.

Inside cells, two important enzymes act like small central regulatory hubs: dipeptidyl peptidase 8 and 9—DPP8/9 for short.

Idorsia Pharmaceuticals has claimed FDA approval for aprocitentan as a treatment for resistant hypertension, becoming the first drug in the endothelin receptor antagonist class for that indication.

the general consensus was that the drug class was an R&D dead end. Merck's exit came after other companies including Pfizer, Eli Lilly and Roche all scrapped CETP development programmes following ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Blue Cross Blue Shield mandates severe asthma patients self-administer drugs at home, unless their provider gets prior approval from the company.

because long-acting corticosteroids like dexamethasone do not provide a steroid free period for recovery from adrenal suppression, and prednisone also allows for more flexible dosage adjustments ...